The medical device maker initiates a $1 billion share repurchase program in Q2 while projecting mid-single-digit pro forma revenue growth.
Teleflex Inc. outlined a 2026 pro forma revenue growth target of 4.5% to 5.5%, reflecting expectations for steady expansion in its core markets. The company also announced a $1 billion share buyback program set to begin in the second quarter, ahead of planned divestitures.